Skip to main content
University of Wisconsin–Madison
UW Crest
UW Initiative to End Alzheimer's
Together, we can improve lives and build a future without Alzheimer’s disease — in Wisconsin and beyond.
  • ABOUT Expand Collapse
    • About Us
    • Leadership and Board of Visitors
    • News and Events
    • Subscribe to Our E-newsletter
    • Contact Us
  • WE SUPPORT Expand Collapse
    • Research
    • Education
    • Health Equity
  • MEMORABLE FRIENDS Expand Collapse
    • Why We Give: Featured Friends
    • Become a Memorable Friend
  • WAYS TO GIVE Expand Collapse
    • Ways to Give
    • Donate
  • DONATE
  • UW School of Medicine and Public Health
  1. Home
  2. Tag: AHEAD study

AHEAD study

Companies announce findings about potential new Alzheimer’s drug lecanemab

Posted on September 30, 2022

Dr. Cynthia Carlsson, MD, MS spoke to multiple media outlets about the news, sharing information about a current UW study investigating use of lecanemab.

Posted in IEA NewsTagged AHEAD study, Dr. Cynthia Carlsson, lecanemab

Site footer content

University logo that links to main university website Part of the Universities of Wisconsin

Quick Links

  • About Us
  • News and Events
  • Memorable Friends
  • Donate

Contact Us

  • University of Wisconsin
    Madison, WI 53703
  • Email: iea@supportuw.org
  • Phone: 608-308-5167
    • facebook
    • x twitter
    • instagram
    • youtube

Website feedback, questions or accessibility issues: iea@medicine.wisc.edu | Learn more about accessibility at UW–Madison.

This site was built using the UW Theme Classic | Privacy Notice | © 2026 Board of Regents of the University of Wisconsin System.